Synaptiflora is an AI-powered SaaS platform that integrates microbiome, genomic, and clinical data to predict drug response, improve patient stratification, and accelerate clinical trials. Backed by a proprietary database and validated by pharma leaders, our technology reduces trial costs, identifies novel biomarkers, and enables precision drug development across oncology, immunology, and beyond.
Synaptiflora
AI-driven microbiome insights to boost drug response and transform drug development.
Market Area: Europe, Middle East, North America & Canada
Headquarter: Israel
More from Synaptiflora
Join
Your go-to destination to spotlight your products and services while connecting with high-value leads in the microbiome sector.
Generate Quality Leads
Tailor a lead generation strategy that aligns with your unique goals.
Expand Your Reach
Position your brand in front of the right audience.
Showcase Your Expertise
Highlight into your company page what makes your business stand out in the microbiome field
